273 related articles for article (PubMed ID: 8548936)
1. Vitamin D intoxication causes hypercalcaemia by increased bone resorption which responds to pamidronate.
Selby PL; Davies M; Marks JS; Mawer EB
Clin Endocrinol (Oxf); 1995 Nov; 43(5):531-6. PubMed ID: 8548936
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D intoxication and hypercalcaemia in an infant treated with pamidronate infusions.
Ezgu FS; Buyan N; Gündüz M; Tümer L; Okur I; Hasanoglu A
Eur J Pediatr; 2004 Mar; 163(3):163-5. PubMed ID: 14714183
[TBL] [Abstract][Full Text] [Related]
3. The use of pamidronate for hypercalcemia secondary to acute vitamin D intoxication.
Lee DC; Lee GY
J Toxicol Clin Toxicol; 1998; 36(7):719-21. PubMed ID: 9865241
[TBL] [Abstract][Full Text] [Related]
4. Hypercalcaemia due to sarcoidosis corrects with bisphosphonate treatment.
Gibbs CJ; Peacock M
Postgrad Med J; 1986 Oct; 62(732):937-8. PubMed ID: 3774726
[TBL] [Abstract][Full Text] [Related]
5. Pamidronate. A review of its use in the management of osteolytic bone metastases, tumour-induced hypercalcaemia and Paget's disease of bone.
Coukell AJ; Markham A
Drugs Aging; 1998 Feb; 12(2):149-68. PubMed ID: 9509293
[TBL] [Abstract][Full Text] [Related]
6. Treatment of cancer associated hypercalcaemia with combined aminohydroxypropylidene diphosphonate and calcitonin.
Ralston SH; Alzaid AA; Gardner MD; Boyle IT
Br Med J (Clin Res Ed); 1986 Jun; 292(6535):1549-50. PubMed ID: 3087513
[TBL] [Abstract][Full Text] [Related]
7. Immobilization-related hypercalcaemia--a possible novel mechanism and response to pamidronate.
Gallacher SJ; Ralston SH; Dryburgh FJ; Logue FC; Allam BF; Boyce BF; Boyle IT
Postgrad Med J; 1990 Nov; 66(781):918-22. PubMed ID: 2267202
[TBL] [Abstract][Full Text] [Related]
8. Comparison of aminohydroxypropylidene diphosphonate, mithramycin, and corticosteroids/calcitonin in treatment of cancer-associated hypercalcaemia.
Ralston SH; Gardner MD; Dryburgh FJ; Jenkins AS; Cowan RA; Boyle IT
Lancet; 1985 Oct; 2(8461):907-10. PubMed ID: 2865417
[TBL] [Abstract][Full Text] [Related]
9. Hypercalcaemia in primary oxalosis: role of increased bone resorption and effects of treatment with pamidronate.
Yamaguchi K; Grant J; Noble-Jamieson G; Jamieson N; Barnes ND; Compston JE
Bone; 1995 Jan; 16(1):61-7. PubMed ID: 7742085
[TBL] [Abstract][Full Text] [Related]
10. A randomised double-blind comparison of intravenous pamidronate and clodronate in the hypercalcaemia of malignancy.
Purohit OP; Radstone CR; Anthony C; Kanis JA; Coleman RE
Br J Cancer; 1995 Nov; 72(5):1289-93. PubMed ID: 7577484
[TBL] [Abstract][Full Text] [Related]
11. Treatment of tumour-induced hypercalcaemia with the bisphosphonate pamidronate: dose-response relationship and influence of tumour type.
Body JJ; Dumon JC
Ann Oncol; 1994 Apr; 5(4):359-63. PubMed ID: 8075034
[TBL] [Abstract][Full Text] [Related]
12. Pamidronate treatment in acute vitamin D intoxication.
Gurkan F; Davutoglu M; Bosnak M; Ece A; Dikici B; Bilici M; Haspolat K
J Endocrinol Invest; 2004; 27(7):680-2. PubMed ID: 15505994
[TBL] [Abstract][Full Text] [Related]
13. Hypercalcemia and hyperosteolysis in vitamin D intoxication: effects of clodronate therapy.
Rizzoli R; Stoermann C; Ammann P; Bonjour JP
Bone; 1994; 15(2):193-8. PubMed ID: 8086237
[TBL] [Abstract][Full Text] [Related]
14. Pamidronate. A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease.
Fitton A; McTavish D
Drugs; 1991 Feb; 41(2):289-318. PubMed ID: 1709854
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy.
Vinholes J; Guo CY; Purohit OP; Eastell R; Coleman RE
J Clin Oncol; 1997 Jan; 15(1):131-8. PubMed ID: 8996134
[TBL] [Abstract][Full Text] [Related]
16. Hypercalcaemia in osteogenesis imperfecta treated with pamidronate.
Williams CJ; Smith RA; Ball RJ; Wilkinson H
Arch Dis Child; 1997 Feb; 76(2):169-70. PubMed ID: 9068314
[TBL] [Abstract][Full Text] [Related]
17. Immobilization hypercalcaemia responding to intravenous pamidronate sodium therapy.
McIntyre HD; Cameron DP; Urquhart SM; Davies WE
Postgrad Med J; 1989 Apr; 65(762):244-6. PubMed ID: 2594602
[TBL] [Abstract][Full Text] [Related]
18. Comparison of Treatment Regimens in Management of Severe Hypercalcemia Due to Vitamin D Intoxication in Children.
Demir K; Döneray H; Kara C; Atay Z; Çetinkaya S; Çayır A; Anık A; Eren E; Uçaktürk A; Can Yılmaz G; Törel Ergür A; Kendirci M; Aycan Z; Bereket A; Aydın M; Orbak Z; Özkan B
J Clin Res Pediatr Endocrinol; 2019 May; 11(2):140-148. PubMed ID: 30396880
[TBL] [Abstract][Full Text] [Related]
19. Aminohydroxypropylidene bisphosphonate (AHPrBP) treatment of severe immobilization hypercalcaemia in a young patient.
Varache N; Audran M; Clochon P; Lortholary A; Bouachour G; Alquier P; Basle MF
Clin Rheumatol; 1991 Sep; 10(3):328-32. PubMed ID: 1790647
[TBL] [Abstract][Full Text] [Related]
20. Optimal frequency of administration of pamidronate in patients with hypercalcaemia of malignancy.
Wimalawansa SJ
Clin Endocrinol (Oxf); 1994 Nov; 41(5):591-5. PubMed ID: 7828347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
